https://sputnikglobe.com/20220106/us-cdc-recommends-cutting-interval-between-second-booster-vaccines-for-12-17-year-olds-1092052333.html
US CDC Recommends Cutting Interval Between Second, Booster Vaccines for 12-17 Year Olds
US CDC Recommends Cutting Interval Between Second, Booster Vaccines for 12-17 Year Olds
Sputnik International
US CDC Recommends Cutting Interval Between Second, Booster Vaccines for 12-17 Year Olds
2022-01-06T02:27+0000
2022-01-06T02:27+0000
2022-01-06T02:27+0000
us
vaccinations
us centers for disease control (cdc)
coronavirus
https://cdn1.img.sputnikglobe.com/img/07e5/04/10/1082645764_0:62:3073:1790_1920x0_80_0_0_b2c80a990badfbf5468a78a88851f338.jpg
The Advisory Committee members voted 13 to 1 to recommend early boosting for the adolescents in the 12-17 age group.The Advisory Committee said it will soon start recommending being "up to date" on vaccination against the coronavirus instead of urging people to be fully vaccinated. Staying up to date means to get the third dose when eligible, including those individuals with compromised immune systems.At present, only the Pfizer-BioNTech booster vaccine is authorized and recommended for use in adolescents 12-17 years of age.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2022
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e5/04/10/1082645764_71:0:2802:2048_1920x0_80_0_0_bbc1eec77c12ca0bda71ec1d8b91ff9e.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
pfizer-biontech booster vaccine, vaccination for underage, cdc recommends, us advisory committee on immunization practices
pfizer-biontech booster vaccine, vaccination for underage, cdc recommends, us advisory committee on immunization practices
US CDC Recommends Cutting Interval Between Second, Booster Vaccines for 12-17 Year Olds
WASHINGTON (Sputnik) - The US Advisory Committee on Immunization Practices has voted to recommend shortening the interval between primary series of vaccination against the coronavirus and the Pfizer booster shot from six to five months in adolescents aged 12-17 years.
The Advisory Committee members voted 13 to 1 to
recommend early boosting for the adolescents in the 12-17 age group.
"A single Pfizer-BioNTech COVID-19 vaccine booster dose is recommended for persons aged 12-17 years at least five months after primary series under the FDA's Emergency Use Authorization," the Advisory Committee recommendation said on Wednesday.
The Advisory Committee said it will soon start recommending being "up to date" on vaccination against the coronavirus instead of urging people to be fully vaccinated. Staying up to date means to get the third dose when eligible, including those individuals with compromised immune systems.
At present, only the Pfizer-BioNTech booster vaccine is authorized and recommended for use in adolescents 12-17 years of age.